A Study to Evaluate Effects of KN056 in Healthy Participants

Clinical trial NCT05385575 · COMPLETED

Trial details

NCT number: NCT05385575
Sponsor: Suzhou Alphamab Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2022-08-09
Primary completion: 2023-12-22
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.